Demolition creates space for something new
Our client develops state-of-the-art vaccines in Düsseldorf with a high level of expertise in the field of toll-like receptor (TLR) biology.
Following the successful completion of the first construction phase (Hall B 4) in 2021-2022, the second construction phase is now pending. Here, we will be gutting and rebuilding the laboratory and production facilities in order to optimally adapt the premises in building B 1 and the sampling area in B 2 to current requirements.
From planning to implementation, we are carrying out the project in a construction team model – efficiently and in partnership.